Adverse events155

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 155

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Abdominal distention	Gastrointestinal disorders	IMC-A12 Monotherapy in Patients	1	49	1
other	Abdominal pain	Gastrointestinal disorders	IMC-A12 Monotherapy in Patients	3	49	3
other	Activated partial thromboplastin time prolonged	Blood and lymphatic system disorders	IMC-A12 Monotherapy in Patients	7	49	12
other	Acute coronary syndrome	Cardiac disorders	IMC-A12 Monotherapy in Patients	2	49	2
other	Alanine aminotransferase increased	Metabolism and nutrition disorders	IMC-A12 Monotherapy in Patients	23	49	60
other	Alkaline phosphatase increased	Metabolism and nutrition disorders	IMC-A12 Monotherapy in Patients	17	49	31
other	Allergic reaction	Immune system disorders	IMC-A12 Monotherapy in Patients	2	49	2
other	Allergic rhinitis	Immune system disorders	IMC-A12 Monotherapy in Patients	7	49	7
other	Alopecia	Skin and subcutaneous tissue disorders	IMC-A12 Monotherapy in Patients	7	49	7
other	Anemia	Blood and lymphatic system disorders	IMC-A12 Monotherapy in Patients	35	49	105
other	Cough	Respiratory, thoracic and mediastinal disorders	IMC-A12 Monotherapy in Patients	16	49	31
other	Diarrhea	Gastrointestinal disorders	IMC-A12 Monotherapy in Patients	9	49	22
other	Dizziness	Nervous system disorders	IMC-A12 Monotherapy in Patients	5	49	8
other	Dry eye	Eye disorders	IMC-A12 Monotherapy in Patients	2	49	2
other	Dry mouth	Gastrointestinal disorders	IMC-A12 Monotherapy in Patients	2	49	2
other	Dry skin	Skin and subcutaneous tissue disorders	IMC-A12 Monotherapy in Patients	6	49	6
other	Dysgeusia	Gastrointestinal disorders	IMC-A12 Monotherapy in Patients	2	49	2
other	Dyspnea	Respiratory, thoracic and mediastinal disorders	IMC-A12 Monotherapy in Patients	13	49	20
other	Ear and labyrinth disorders - Other, specify (patient reports of diminished hearing)	Ear and labyrinth disorders	IMC-A12 Monotherapy in Patients	1	49	1
other	Edema: limbs	Blood and lymphatic system disorders	IMC-A12 Monotherapy in Patients	1	49	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00965250/events

API reference For AI assistants

Adverse events155

Sources 3

Read this list from software.